Figures & data
Figure 1. Cell cycle profiles and p27 expression in synchronized 3T3PB and Bcl−2 cells by SS or CI followed by re-stimulation. (A) Bcl−2 expression in 293T, 3T3 and C3H cells. (B, C) Cell cycle profile of 3T3PB and Bcl−2 cells (D, E) Percentage of S phase cells during re-stimulation in serum-starved SS3T3 and contact inhibited 3T3 cells. (F, G). Western blot of p27 in normal growing and synchronized cells. PB: PBABE empty vector stable transfected; Bcl−2: pBABEneo-Bcl−2 stable transfected. CI: contact inhibition SS: serum starvation NG: normal growing
![Figure 1. Cell cycle profiles and p27 expression in synchronized 3T3PB and Bcl−2 cells by SS or CI followed by re-stimulation. (A) Bcl−2 expression in 293T, 3T3 and C3H cells. (B, C) Cell cycle profile of 3T3PB and Bcl−2 cells (D, E) Percentage of S phase cells during re-stimulation in serum-starved SS3T3 and contact inhibited 3T3 cells. (F, G). Western blot of p27 in normal growing and synchronized cells. PB: PBABE empty vector stable transfected; Bcl−2: pBABEneo-Bcl−2 stable transfected. CI: contact inhibition SS: serum starvation NG: normal growing](/cms/asset/3fc31014-ad05-4330-84fb-4fbcb50a3771/kccy_a_1295182_f0001_b.gif)
Figure 2. The effects of ATP alteration on cell cycle arrest in 3T3PB and 3T3Bcl−2 cells. (A)The ATP levels during re-stimulation. (B) Cell cycle profiles with addition of various dose of ATP sodium salt after re-stimulation. (C) Graph of the percentage of S phase cells in B. (D) Cell cycle profiles with oligomycinA treatment after re-stimulation. (E) Graph of the percentage of S phase cells in B. (F) Detection of ATP level with oligomycinA treatment.
![Figure 2. The effects of ATP alteration on cell cycle arrest in 3T3PB and 3T3Bcl−2 cells. (A)The ATP levels during re-stimulation. (B) Cell cycle profiles with addition of various dose of ATP sodium salt after re-stimulation. (C) Graph of the percentage of S phase cells in B. (D) Cell cycle profiles with oligomycinA treatment after re-stimulation. (E) Graph of the percentage of S phase cells in B. (F) Detection of ATP level with oligomycinA treatment.](/cms/asset/181207ab-6f0d-4bff-9c55-be30ce6d4ef2/kccy_a_1295182_f0002_oc.gif)
Figure 3. Detection of ROS levels by flow cytometer. (A) ROS levels in synchronized 3T3PB and Bcl−2 cells by CI treatment. (B) ROS levels in synchronized 3T3PB and Bcl−2 cells by SS treatment. (C) Reduction of ROS level by 20 mmol/L GSH treatment.
![Figure 3. Detection of ROS levels by flow cytometer. (A) ROS levels in synchronized 3T3PB and Bcl−2 cells by CI treatment. (B) ROS levels in synchronized 3T3PB and Bcl−2 cells by SS treatment. (C) Reduction of ROS level by 20 mmol/L GSH treatment.](/cms/asset/b1db7f58-1f40-466c-ad53-c7fbe012ff26/kccy_a_1295182_f0003_oc.gif)